XML 58 R48.htm IDEA: XBRL DOCUMENT v3.22.1
Debt (Details Narrative) - USD ($)
 2 Months Ended 3 Months Ended
Feb. 22, 2022
Oct. 25, 2021
Sep. 13, 2021
Mar. 03, 2022
Mar. 31, 2022
Dec. 31, 2021
Short-Term Debt [Line Items]            
Original issue discount           8.00%
Fair value of warrants         $ 7,000,000.0  
Amortized debt discount         1,800,000  
Face amount         16,300,000  
Purchase price       $ 15,000,000.0    
Debt amortized         700,000  
Debt issuance costs         $ 1,300,000  
Unsecured lines of credit     $ 1,000,000.0      
Interest rate     4.25%      
Line of credit maximum amount     $ 1,000,000.0      
Tranche One [Member]            
Short-Term Debt [Line Items]            
Aggregate principal amount $ 7,600,000          
Description of aggregate purchase price The Company issued to the Lenders a third tranche of promissory notes in an aggregate principal amount of $10.0 million for an aggregate purchase price of $10.0 million (the “Third Tranche Notes” and, together with the First Tranche Notes and Second Tranche Notes, the “Notes”) along with Class D common stock purchase warrants (collectively, the “Warrants”) to purchase up to an aggregate of 1,000,000 shares of common stock of the Company, at an exercise price of $11.50 per share on April 13, 2022.          
Tranche Two [Member]            
Short-Term Debt [Line Items]            
[custom:AggregateFinancingValue] $ 20,000,000          
Convertible Notes Payable [Member]            
Short-Term Debt [Line Items]            
Description of accredited investors   the Company issued to certain accredited investors (i) secured convertible notes in an aggregate principal amount of $16.3 million for an aggregate purchase price of $15 million (collectively, the “Notes”), which are, subject to certain conditions, convertible at any time by the investors, into an aggregate of 1,776,073 shares (the “Conversion Shares”) of the Company’s common stock, at a price per share of $9.18 (the “Fixed Conversion Price”) and (ii) Class A, Class B and Class C common stock purchase warrants (collectively, the “Warrants”) to purchase up to an aggregate of 1,776,073 shares of common stock, at an exercise price $12.50, $15 and $18 per share, respectively. The Warrants are legally detachable and can be separately exercised immediately for five years upon issuance, subject to applicable Nasdaq rules.        
Promissory Notes [Member]            
Short-Term Debt [Line Items]            
Aggregate principal amount $ 2,400,000